The role of infection in carotid plaque pathogenesis and stability: The clinical evidence

Current Vascular Pharmacology

Volumn 8, Issue 6, 2010, Pages 861-872

  Makris, Gregory C ^a,c,d   Makris, Marinos C ^a   Wilmot, Victoria V ^c   Geroulakos, George ^c,d   Falagas, Matthew E ^a,b  

^a ALFA INSTITUTE OF BIOMEDICAL SCIENCES AIBS   (Greece)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c EALING HOSPITAL   (United Kingdom)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Antibiotics; Antivirals; Carotid plaque; Infection

Indexed keywords

ANTIINFECTIVE AGENT; ANTIVIRUS AGENT; HEME OXYGENASE 1; IMMUNOGLOBULIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; TUMOR NECROSIS FACTOR ALPHA;

ADENOVIRUS; ANTIBIOTIC THERAPY; ANTIVIRAL THERAPY; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROTIC PLAQUE; BACTERIAL INFECTION; BACTERIAL STRAIN; BACTERIUM; BACTERIUM DETECTION; BACTERIUM IDENTIFICATION; BORRELIA BURGDORFERI; CAROTID ATHEROSCLEROSIS; CAROTID ENDARTERECTOMY; CHLAMYDOPHILA PNEUMONIAE; CORYNEBACTERIUM DIPHTHERIAE; CYTOMEGALOVIRUS; DATA EXTRACTION; DISEASE ASSOCIATION; ENTEROVIRUS; ENZYME LINKED IMMUNOSORBENT ASSAY; HELICOBACTER PYLORI; HEMODIALYSIS; HEPATITIS B; HEPATITIS C VIRUS; HERPES VIRUS INFECTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNOASSAY; IMMUNOHISTOCHEMISTRY; INFECTION RATE; INFLUENZA VIRUS A; INFORMATION RETRIEVAL; LYMPH NODE; MEDLINE; MYCOBACTERIUM TUBERCULOSIS; OXIDATIVE STRESS; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; PORPYROMONAS GINGIVALIS; PRIMARY PREVENTION; PROTEIN EXPRESSION; SECONDARY PREVENTION; SERODIAGNOSIS; SEROLOGY; STAPHYLOCOCCUS; TREATMENT OUTCOME; VACCINATION; VIRUS INFECTION;

EID: 78649358087     PISSN: 15701611     EISSN: None     Source Type: Journal    
DOI: 10.2174/157016110793563889     Document Type: Article

References (63)

1. Athyros VG, Kakafika AI, Karagiannis A, Mikhailidis DP. Do weneed to consider inflammatory markers when we treat atheroscleroticdisease? Atherosclerosis 2008; 200: 1-12.
2. Ismail A, Khosravi H, Olson H. The role of infection in atherosclerosisand coronary artery disease: a new therapeutic target. HeartDis 1999; 1: 233-40.
3. Watson C, Alp N. Role of Chlamydia pneumoniae in atherosclerosis.Clin Sci 2008; 114: 509-31.
4. Andraws R, Berger JS, Brown DL. Effects of antibiotic therapy onoutcomes of patients with coronary artery disease: a meta-analysisof randomized controlled trials. JAMA 2005; 293: 2641-7.
5. Song Z, Brassard P, Brophy JM. A meta-analysis of antibiotic usefor the secondary prevention of cardiovascular disease. Can JCardiol 2008; 24: 391-5.
6. Müller BT, Huber R, Henrich B, et al. Chlamydia pneumoniae,herpes simplex virus and cytomegalovirus in symptomatic and asymptomatichigh-grade internal carotid artery stenosis. Does infectioninfluence plaque stability? Vasa 2005; 34: 163-9.
7. Katsenis C, Kouskouni E, Kolokotronis L, Rizos D, Dimakakos P.The significance of Chlamydia pneumoniae in symptomatic carotidstenosis. Angiology 2001; 52: 615-9.
8. Kaperonis EA, Liapis CD, Kakisis JD, Perrea D, Kostakis AG, Karayannakos PE. The association of carotid plaque inflammationand Chlamydia pneumoniae infection with cerebrovascular symptomatology.J Vasc Surg 2006; 44: 1198-204.
9. Sessa R, Di Pietro M, Schiavoni G, Santino I, Benedetti-Valentini F, Perna R. Chlamydi pneumoniae DNA in patients with symptomaticcarotid atherosclerotic disease. J Vasc Surg 2003; 37: 127-31.
10. La Biche R, Koziol D, Quinn TC, et al. Presence of Chlamydiapneumoniae in human symptomatic and asymptomatic carotid atheroscleroticplaque. Stroke 2001; 32: 855-60.
11. Ameriso SF, Villamil AR, Zedda C, et al. Heme oxygenase-1 isexpressed in carotid atherosclerotic plaques infected by Helicobacterpylori and is more prevalent in asymptomatic subjects. Stroke 2005; 36: 1901-3.
12. Ishizaka N, Ishizaka Y, Takahashi E, et al. Increased prevalence ofcarotid atherosclerosis in hepatitis B virus carriers. Circulation 2002; 105: 1028-30.
13. Völzke H, Schwahn C, Wolff B, et al. Hepatitis B and C virusinfection and the risk of atherosclerosis in a general population.Atherosclerosis 2004; 177: 211-4.
14. Qavi HB, Melnick JL, Adam E, Debakey ME. Frequency of coexistenceof cytomegalovirus and Chlamydia pneumoniae in atheroscleroticplaques. Cent Eur J Public Health 2000; 8: 71-3.
15. Caliskan Y, Oflaz H, Pusuroglu H, et al. Hepatitis C virus infectionin haemodialysis patients is not associated with insulin resistance,inflammation and atherosclerosis. Clin Nephrol 2009; 71: 147-57.
16. Leone S, Amitrano M, D'Avanzo A, Acone N, Giglio S. Carotidartery intima-media thickness in highly treated HIV-1 patients.Infez Med 2008; 16: 15-20.
17. Maggi P, Perilli F, Lillo A, et al. Rapid progression of carotidlesions in HAART-treated HIV-1 patients. Atherosclerosis 2007;192: 407-12.
18. Jericó C, Knobel H, Calvo N, et al. Subclinical carotid atherosclerosisin HIV-infected patients: role of combination antiretroviraltherapy. Stroke 2006; 37: 812-7.
19. Hagiwara N, Toyoda K, Inoue T, et al. Lack of association betweeninfectious burden and carotid atherosclerosis in Japanese patients. JStroke Cerebrovasc Dis 2007; 16: 145-52.
20. Corrado E, Rizzo M, Tantillo R, et al. Markers of inflammationand infection influence outcome of patients with baseline asymptomaticcarotid lesions: a 5-year follow-up study. Stroke 2006; 37:482-6.
21. Latsios G, Saetta A, Michalopoulos NV, Agapitos E, Patsouris E. Detection of cytomegalovirus, Helicobacter pylori and Chlamydiapneumoniae DNA on carotid atherosclerotic plaques by polymerasechain reaction. Acta Cardiol 2004; 59: 652-7.
22. Haratzhy VI, Zambon JJ, Trevisan M, Zeid M, Genco RJ. Identificationof periodontal pathogens in atheromatous plaques. J Periodontol 2000; 71: 1554-60.
23. Kwon TW, Kim DK, Ye JS, et al. Detection of enterovirus, cytomegalovirusand Chlamydia pneumoniae in atheromas. J Microbiol 2004; 42: 299-304.
24. Halvorsen DS, Karlsen J, Notø AT, et al. No detectable Chlamydiapneumoniae and cytomegalovirus DNA in leukocytes in subjectswith echolucent and echogenic carotid artery plaques. Int J Cardiol 2007; 117: 388-94.
25. Hunter GC, Henderson AM, Westerband A, et al. The contributionof inducible nitric oxide and cytomegalovirus to the stability ofcomplex carotid plaque. J Vasc Surg 1999; 30: 36-49.
26. Ishizaka N, Ishizaka Y, Takahashi E, Tooda E, Hashimoto H, Nagai R. Association between hepatitis C virus seropositivity, carotid-artery plaque and intima-media thickening. Lancet 2002; 359:133-5.
27. Boddi M, Abbate R, Chellini B, et al. HCV infection facilitatesasymptomatic carotid atherosclerosis: preliminary report of HCVRNA localization in human carotid plaques. Dig Liver Dis 2007;39 (Supp1): S55-60.
28. Ishizaka N, Ishizaka Y, Takahashi E, Unuma T, Tooda E, Hashimoto H. Association between hepatitis C virus core proteinand carotid atherosclerosis. Circ J 2003; 67: 26-30.
29. Yang KC, Chen MF, Su TC, et al. Hepatitis B virus seropositivityis not associated with increased risk of carotid atherosclerosis inTaiwanese. Atherosclerosis 2007; 195: 392-7.
30. De Boer OJ, Teeling P, Idu MM, Becker AE, Van Der Wal AC. Epstein Barr virus specific T-cells generated from unstable humanatherosclerotic lesions: implications for plaque inflammation. Atherosclerosis 2006; 184: 322-9.
31. Keller TT, Van De Meer JJ, Teeling P, et al. Selective expansion ofinfluenza A virus-specific T cells in symptomatic human carotid arteryatherosclerotic plaque. Stroke 2008; 39: 174-9.
32. Völzke H, Wolff B, Lüdemann J, et al. Seropositivity for anti-Borrelia IgG antibody is independently associated with carotidatherosclerosis. Atherosclerosis 2006; 184: 108-12.
33. Malnick SD, Goland S, Kaftoury A, Schwarz H, Pasik S, Mashiach A. Evaluation of carotid arterial plaques after endarterectomy forHelicobacter pylori infection. Am J Cardiol 1999; 83: 1586-7.
34. Ford PJ, Gemmell E, Chan A, et al. Inflammation, heat shock proteinsand periodontal pathogens in atherosclerosis: an immunohistologicstudy. Oral Microbiol Immunol 2006; 21: 206-11.
35. Taniguchi A, Nishimura F, Murayama Y, et al. Porphyromonasgingivalis infection is associated with carotid atherosclerosis innon-obese Japanese type 2 diabetic patients. Metabolism 2003; 52:142-5.
36. Mastragelopoulos N, Haraszthy VI, Zambon JJ, Zafiropoulos GG. Detection of periodontal pathogenic microorganisms in atheromatousplaque. Chirurg 2002; 73: 585-91.
37. Romano F, Barbui A, Aimetti M. Periodontal pathogens in periodontalpockets and in carotid atheromatous plaques. MinervaStomatol 2007; 56: 169-79.
38. Giral P, Kahn JF, André JM, et al. Carotid atherosclerosis is notrelated to past tuberculosis in hypercholesterolemic patients. Atherosclerosis 2007; 190: 150-5.
39. Paget CJ, Wolk SW, Whitehouse WM, et al. Incidence and pathophysiologicsignificance of infected carotid artery plaque. AnnVasc Surg 1997; 11: 129-32.
40. Milio G, Corrado E, Sorrentino D, et al. Asymptomatic carotidlesions and aging: role of hypertension and other traditional andemerging risk factors. Arch Med Res 2006; 37: 342-7.
41. Neureiter D, Heuschmann P, Stintzing S, et al. Detection ofChlamydia pneumoniae but not Helicobacter pylori in symptomaticatherosclerotic carotids associated with enhanced serum antibodies,inflammation and apoptosis rate. Atherosclerosis 2003; 168: 153-62.
42. Ameriso SF, Fridman EA, Leiguarda RC, Sevlever GE. Detectionof Heliocobacter pylori in human carotid plaques. Stroke 2001; 32:385-91.
43. Farzak B, Yildirir A, Akyön Y, et al. Detection of Chlamydiapneumoniae and Helicobacter pylori DNA in human atheroscleroticplaques by PCR. J Clin Microbiol 2000; 38: 4408-11.
44. Gabrielli M, Santoliquido A, Cremonini F, et al. CagA-positivecytotoxic H. pylori strains as a link between plaque instability andatherosclerotic stroke. Eur Heart J 2004; 25: 64-8.
45. van de Meer JJ, van der Wal AC, Teeling P, Idu MM, van der Ende A, de Boer OJ. Multiple bacteria contribute to intraplaque T-cellactivation in atherosclerosis. Eur J Clin Invest 2008; 38: 857-62.
46. Weiss TW, Kvakan H, Kaun C, Prager M, Speidl WS. No evidencefor direct role of Helicobacter pylori and Mycoplasma pneumoniaein carotid artery atherosclerosis. J Clin Pathol 2006; 59: 1186-90.
47. Dore MP, Sepulveda AR, Bacciu PP, et al. Detection of Chlamydiapneumoniae but not Helicobacter pylori DNA in atherosclerosisplaques. Dig Dis Sci 2003; 48: 945-51.
48. Elkind MS, Cheng J, Boden-Albala B, Rundek T. Tumour necrosisfactor receptor levels are associated with carotid atherosclerosis.Stroke 2002; 33:37-38.
49. Neri Serneri GG, Prisco D, Martini F, et al. Acute T cell Activationis Detectable in Unstable Angina. Circulation 1997; 95: 1806-12.
50. Nadareishvilli ZG, Koziol DE, Szekely B, et al. Increased CD8(+)T cells associated with Chlamydia pneumoniae in symptomatic carotidplaque. Stroke 2001; 32: 1966-72.
51. Xenaki E, Hassoulas J, Apostolakis S, Sourvinos G, Spandidos DA. Detection of cytomegalovirus in atherosclerotic plaques and nonatheroscleroticarteries. Angiology 2009; 60: 504-8.
52. Mason A, Wick M, White H, et al. Hepatitis B virus replication indiverse cell types during chronic hepatitis B infection. Hepatology 1993; 18: 781-9.
53. Guillevin L, Lhote F, Gherardi R. The spectrum and treatment ofvirus associated vasculidities. Curr Opin Rheumatol 1997; 9: 31-6.
54. Marchesini G, Ronchi M, Forlani G, et al. Cardiovascular diseasein cirrhosis-a point-prevalence study in relation to glucose tolerance. Am J Gastroenterol 1999; 94: 655-62.
55. Lavallée P, Perchaud V, Gautier-Bertrand M, Grabli D, Amarenco P. Association between influenza vaccination and reduced risk ofbrain infarction. Stroke 2002; 33: 513-8.
56. Nichol KL, Nordin J, Mmullooly J, Lask R, Fillbrandt K, Iwane M. Influenza vaccination and reduction in hospitalizations for cardiacdisease and stroke among the elderly. N Engl J Med, 2003; 348:1322-32.
57. Koutouzis M, Paraskevas KI, Rallidis LS, et al. Statin treatment,carotid atherosclerotic plaque macrophage infiltration and circulatinginflammatory markers. Open Cardiovasc Med J 2008; 2: 110-4.
58. Niessner A, Shin MS, Pryshchep O, Goronzy JJ, Chaikof EL, Weyand CM. Synergistic proinflammatory effects of the antiviralcytokine interferon-alpha and Toll-like receptor 4 ligands in theatherosclerotic plaque. Circulation 2007; 116: 2043-52.
59. Streblow DN, Dumortier J, Moses AV, Orloff SL, Nelson JA. Mechanisms of cytomegalovirus-accelerated vascular disease: inductionof paracrine factors that promote angiogenesis and woundhealing. Curr Top Microbiol Immunol 2008; 325: 397-415.
60. van Es T, van Puijvelde GH, Foks AC, et al. Vaccination againstFoxp3(+) regulatory T cells aggravates atherosclerosis. Atherosclerosis 2010; 209(1): 74-80.
61. Hauer AD, Habets KL, van Wanrooij EJ, et al. Vaccination againstTIE2 reduces atherosclerosis. Atherosclerosis 2009; 204: 365-71.
62. Falagas ME, Makris GC, Matthaiou DK, Rafailidis PI. Statins forinfection and sepsis: a systematic review of the clinical evidence. JAntimicrob Chemother 2008; 61: 774-85.
63. Kopterides P, Falagas ME. Statins for sepsis: a critical and updatedreview. Clin Microbiol Infect 2009; 15: 325-34.